Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)

Clinical trial NCT02013648 · COMPLETED

Trial details

NCT number: NCT02013648
Sponsor: University of Ulm
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2014-07-01
Primary completion: 2024-02-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.